CLPT
Clearpoint Neuro Inc
Price:  
25.27 
USD
Volume:  
466,216.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CLPT EV/EBITDA

-166.4%
Upside

As of 2025-10-24, the EV/EBITDA ratio of Clearpoint Neuro Inc (CLPT) is -33.13. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CLPT's latest enterprise value is 718.43 mil USD. CLPT's TTM EBITDA according to its financial statements is -21.68 mil USD. Dividing these 2 quantities gives us the above CLPT EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 19.4x - 22.0x 21.0x
Forward P/E multiples 21.5x - 24.0x 23.0x
Fair Price (16.40) - (16.79) (16.78)
Upside -164.9% - -166.5% -166.4%
25.27 USD
Stock Price
(16.78) USD
Fair Price

CLPT EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA